ThinkEquity analyst Ashok Kumar initiated coverage of Reunion Neuroscience with a Buy rating and $5 price target.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on REUN:
- Reunion Neuroscience Announces Presentation at 2023 Bloom Burton & Co. Healthcare Investor Conference
- Reunion Neuroscience receives notice of non-compliance from Nasdaq
- Reunion Neuroscience Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
- Reunion Neuroscience appoints Grossman to board of directors
- Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors